Jupiter Neurosciences to Showcase JOTROL Platform at 9:00 AM ET Wall Street Summit May 5
Jupiter Neurosciences will present its JOTROL™ resveratrol platform at The Market Movers Investor Summit on May 5 at 9:00 AM ET at 48 Wall Street, led by CEO Christer Rosén. The event’s high-access format offers one-on-one meetings with fund managers and family offices ahead of its Phase IIa Parkinson’s trial.
1. Summit Participation Details
Jupiter Neurosciences will present at The Market Movers Investor Summit on May 5, 2026 at 9:00 AM ET at 48 Wall Street in New York. Christer Rosén, Chairman and Chief Executive Officer, will lead the presentation, highlighting the company’s clinical and consumer strategies.
2. Networking and Presentation Format
The summit features company presentations, fireside chats, keynote sessions and one-on-one meetings with fund managers and family offices inside the historic Bank of New York. Attendees will have access to high-caliber networking opportunities designed to facilitate capital and strategic partnerships.
3. Pipeline Focus and Strategic Aims
Jupiter is advancing JOTROL™, its proprietary enhanced resveratrol formulation, through a Phase IIa Parkinson’s disease trial while expanding its Nugevia™ consumer longevity line. The dual-path strategy targets neuroinflammation and healthy aging across CNS disorders and rare diseases.